Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate CEL-SCI Corporation before investing.

In this article, we go over a few key elements for understanding CEL-SCI Corporation’s stock price such as:

• CEL-SCI Corporation’s current stock price and volume
• Why CEL-SCI Corporation’s stock price changed recently
• Upgrades and downgrades for CVM from analysts
• CVM’s stock price momentum as measured by its relative strength

About CEL-SCI Corporation (CVM)

Before we jump into CEL-SCI Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company’s lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company’s LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Want to learn more about CEL-SCI Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about CEL-SCI Corporation.

CEL-SCI Corporation’s Stock Price as of Market Close

As of August 05, 2026, 4:00 PM, CST, CEL-SCI Corporation’s stock price was $1.520.

CEL-SCI Corporation is up 11.76% from its previous closing price of $1.360.

During the last market session, CEL-SCI Corporation’s stock traded between $1.360 and $1.540. Currently, there are approximately 8.14 million shares outstanding for CEL-SCI Corporation.

CEL-SCI Corporation’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

CEL-SCI Corporation Stock Price History

CEL-SCI Corporation’s (CVM) price is currently up 31.03% so far this month.

During the month of August, CEL-SCI Corporation’s stock price has reached a high of $1.540 and a low of $1.150.

Over the last year, CEL-SCI Corporation has hit prices as high as $13.477 and as low as $0.890. Year to date, CEL-SCI Corporation’s stock is down 71.1%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused CEL-SCI Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 05, 2026, there were analysts who downgraded CEL-SCI Corporation’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate CEL-SCI Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on CEL-SCI Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about CEL-SCI Corporation (CVM) by visiting AAII Stock Evaluator.

Relative Price Strength of CEL-SCI Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 05, 2026, CEL-SCI Corporation has a weighted four-quarter relative price strength of -26.00%, which translates to a Momentum Score of 8 and is considered to be Very Weak.

Want to learn more about how CEL-SCI Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

CEL-SCI Corporation Stock Price: Bottom Line

As of August 5, 2026, CEL-SCI Corporation’s stock price is $1.520, which is up 11.76% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like CEL-SCI Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.